Publications by authors named "David Reuter"

Claim this Profile
T
The postural impact of the gravid uterus on the renal veins and its clinical significance.
Jennifer L Anderson, Joanna M Izewski, Juliet M Prieto, Alexis L Green, Kaitlyn M Enderle, David G Reuter

J Matern Fetal Neonatal Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Navitoclax safety, tolerability, and effect on biomarkers of senescence and neurodegeneration in aged nonhuman primates.
Edward F Greenberg, Martin J Voorbach, Alexandra Smith, David R Reuter, Yuchuan Zhuang

Heliyon· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maternal posture-physiology interactions in human pregnancy: a narrative review.
Allan J Kember, Jennifer L Anderson, Natalyn E Gorazd, Sarah C House, Katherine E Kerr, David G Reuter

Front Physiol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of maternal posture on fetal physiology in human pregnancy: a narrative review.
Allan J Kember, Jennifer L Anderson, Sarah C House, David G Reuter, Craig J Goergen

Front Physiol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Navigating the Regulatory Pathway for Medical Devices-a Conversation with the FDA, Clinicians, Researchers, and Industry Experts.
Aaron E Lottes, Kenneth J Cavanaugh, Yvonne Yu-Feng Chan, Vincent J Devlin, Craig J Goergen, David G Reuter

J Cardiovasc Transl Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[F]BTK-1: A Novel Positron Emission Tomography Tracer for Imaging Bruton's Tyrosine Kinase.
Marc B Skaddan, Dustin W Wooten, Kyle C Wilcox, Martin J Voorbach, David R Reuter

Mol Imaging Biol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward Automation of the Supine Pressor Test for Preeclampsia.
Hamna J Qureshi, Jessica L Ma, Jennifer L Anderson, Brett M Bosinski, Aditi Acharya, David G Reuter

J Eng Sci Med Diagn Ther· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of ABBV-221, a Tumor-Selective EGFR-Targeting Antibody Drug Conjugate.
Andrew C Phillips, Erwin R Boghaert, Kedar S Vaidya, Hugh D Falls, Michael J Mitten, David R Reuter

Mol Cancer Ther· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can preeclampsia be considered a renal compartment syndrome? A hypothesis and analysis of the literature.
David G Reuter, Yuk Law, Wayne C Levy, Stephen P Seslar, R Eugene Zierler

J Am Soc Hypertens· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coronary sinus-based percutaneous annuloplasty as treatment for functional mitral regurgitation: the TITAN II trial.
Janusz Lipiecki, Tomasz Siminiak, Horst Sievert, Jochen Müller-Ehmsen, Hubertus Degen, David Reuter

Open Heart· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Image quality of Zr-89 PET imaging in the Siemens microPET Focus 220 preclinical scanner.
Tyler J Bradshaw, Martin J Voorbach, David R Reuter, Anthony M Giamis, Sarah R Mudd

Mol Imaging Biol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-utility analysis of percutaneous mitral valve repair in inoperable patients with functional mitral regurgitation in German settings.
Oleg Borisenko, Michael Haude, Uta C Hoppe, Tomasz Siminiak, Janusz Lipiecki, David G Reuter

BMC Cardiovasc Disord· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical characterization of ABT-348, a kinase inhibitor targeting the aurora, vascular endothelial growth factor receptor/platelet-derived growth factor receptor, and Src kinase families.
Keith B Glaser, Junling Li, Patrick A Marcotte, Terrance J Magoc, Jun Guo, David R Reuter

J Pharmacol Exp Ther· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamic evaluation of irinotecan therapy by FDG and FLT PET/CT imaging in a colorectal cancer xenograft model.
Sarah R Mudd, Kimberley D Holich, Martin J Voorbach, Todd B Cole, David R Reuter

Mol Imaging Biol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN Trial.
Tomasz Siminiak, Justina C Wu, Michael Haude, Uta C Hoppe, Jerzy Sadowski, David G Reuter

Eur J Heart Fail· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrazole diaminopyrimidines as dual inhibitors of KDR and Aurora B kinases.
Michael L Curtin, H Robin Heyman, Robin R Frey, Patrick A Marcotte, Keith B Glaser, David R Reuter

Bioorg Med Chem Lett· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDG-PET as a pharmacodynamic biomarker for early assessment of treatment response to linifanib (ABT-869) in a non-small cell lung cancer xenograft model.
Sarah R Mudd, Martin J Voorbach, David R Reuter, Paul Tapang, Jonathan A Hickson

Cancer Chemother Pharmacol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel multi-targeted tyrosine kinase inhibitor, linifanib (ABT-869), produces functional and structural changes in tumor vasculature in an orthotopic rat glioma model.
Yanping Luo, Fang Jiang, Todd B Cole, Vincent P Hradil, David Reuter

Cancer Chemother Pharmacol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of percutaneous coronary sinus-based mitral valve repair in patients with dilated cardiomyopathy (from the AMADEUS trial).
Tomasz Siminiak, Uta C Hoppe, Joachim Schofer, Michael Haude, Jean-Paul Herrman, David G Reuter

Am J Cardiol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the CARILLON Mitral Annuloplasty Device European Union Study.
Joachim Schofer, Tomasz Siminiak, Michael Haude, Jean P Herrman, Jindra Vainer, David G Reuter

Circulation· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
7
7-Aminopyrazolo[1,5-a]pyrimidines as potent multitargeted receptor tyrosine kinase inhibitors.
Robin R Frey, Michael L Curtin, Daniel H Albert, Keith B Glaser, Lori J Pease, David Reuter

J Med Chem· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of aminopyrazolopyridine ureas as potent VEGFR/PDGFR multitargeted kinase inhibitors.
Yujia Dai, Kresna Hartandi, Niru B Soni, Lori J Pease, David R Reuter

Bioorg Med Chem Lett· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-aminoindazole-based orally active multitargeted receptor tyrosine kinase inhibitor.
Yujia Dai, Kresna Hartandi, Zhiqin Ji, Asma A Ahmed, Daniel H Albert, David R Reuter

J Med Chem· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility and short-term efficacy of percutaneous mitral annular reduction for the therapy of functional mitral regurgitation in patients with heart failure.
Stephen J Duffy, Jacob Federman, Catherine Farrington, David G Reuter, Meroula Richardson

Catheter Cardiovasc Interv· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor.
Daniel H Albert, Paul Tapang, Terrance J Magoc, Lori J Pease, David R Reuter

Mol Cancer Ther· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis